Fig. 1.

Patient selection flowchart. TACE, transarterial chemoembolization; BCLC, Barcelona Clinic Liver Cancer. ^#The timeframe criteria of combination therapy were defined as administration of TACE concurrently with or up to 60 days before camrelizumab, and apatinib was concomitant with TACE or camrelizumab